Involvement of the secosteroid vitamin D in autoimmune rheumatic diseases and COVID-19.
Journal
Nature reviews. Rheumatology
ISSN: 1759-4804
Titre abrégé: Nat Rev Rheumatol
Pays: United States
ID NLM: 101500080
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
accepted:
01
03
2023
medline:
28
4
2023
pubmed:
29
3
2023
entrez:
28
3
2023
Statut:
ppublish
Résumé
Evidence supporting the extra-skeletal role of vitamin D in modulating immune responses is centred on the effects of its final metabolite, 1,25-dihydroxyvitamin D
Identifiants
pubmed: 36977791
doi: 10.1038/s41584-023-00944-2
pii: 10.1038/s41584-023-00944-2
pmc: PMC10043872
doi:
Substances chimiques
Vitamin D
1406-16-2
Calcitriol
FXC9231JVH
Calcifediol
P6YZ13C99Q
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
265-287Informations de copyright
© 2023. Springer Nature Limited.
Références
Carlberg, C. Endocrine functions of vitamin D. Mol. Cell Endocrinol. 453, 1–2 (2017).
pubmed: 28669826
doi: 10.1016/j.mce.2017.06.025
Morris, H. A. & Anderson, P. H. Autocrine and paracrine actions of vitamin D. Clin. Biochem. Rev. 31, 129–138 (2010).
pubmed: 21170259
pmcid: 2998276
Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011).
pubmed: 21646368
doi: 10.1210/jc.2011-0385
Jenkinson, C. The vitamin D metabolome: an update on analysis and function. Cell Biochem. Funct. 37, 408–423 (2019).
pubmed: 31328813
doi: 10.1002/cbf.3421
Bills, C. E. & McDonald, F. G. Antiricketic substances: II. The action of n-Butyl nitrite on activated cholesterol and the antiricketic vitamin. J. Biol. Chem. 66, 451–457 (1925).
doi: 10.1016/S0021-9258(18)84762-7
Selye, H. On the stimulation of new bone-formation with parathyroid extract and irradiated ergosterol. Endocrinology 16, 547–588 (1932).
doi: 10.1210/endo-16-5-547
Windaus, A., Schenk, F. & Werder, F. V. Antirachitically active irradiation product of 7-dehydrocholesterol. Hoppe-Seylers Z. Physiol. Chem. 241, 100–103 (1936).
doi: 10.1515/bchm2.1936.241.1-3.100
Barbáchano, A. et al. The endocrine vitamin D system in the gut. Mol. Cell Endocrinol. 453, 79–87 (2017).
pubmed: 27913273
doi: 10.1016/j.mce.2016.11.028
Glossmann, H. H. Origin of 7-dehydrocholesterol (provitamin D) in the skin. J. Invest. Dermatol. 130, 2139–2141 (2010).
pubmed: 20445550
doi: 10.1038/jid.2010.118
Huff, T., Boyd B., Jialal, I. Physiology, Cholesterol. 2022 Mar 9. In: StatPearls [Internet] (StatPearls, 2022).
Prabhu, A. V., Luu, W., Sharpe, L. J. & Brown, A. J. Cholesterol-mediated degradation of 7-dehydrocholesterol reductase switches the balance from cholesterol to vitamin D synthesis. J. Biol. Chem. 291, 8363–8373 (2016).
pubmed: 26887953
pmcid: 4861412
doi: 10.1074/jbc.M115.699546
Bikle, D. D. et al. 25 Hydroxyvitamin D 1 α-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J. Invest. Dermatol. 122, 984–992 (2004).
pubmed: 15102089
doi: 10.1111/j.0022-202X.2004.22424.x
Liu, P. T. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770–1773 (2006).
pubmed: 16497887
doi: 10.1126/science.1123933
Gray, R. W., Omdahl, J. L., Ghazarian, J. G. & DeLuca, H. F. 25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties. J. Biol. Chem. 247, 7528–7532 (1972).
pubmed: 4404596
doi: 10.1016/S0021-9258(19)44557-2
Prosser, D. E. & Jones, G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29, 664–673 (2004).
pubmed: 15544953
doi: 10.1016/j.tibs.2004.10.005
Bikle, D. D. in Vitamin D: production, metabolism and mechanisms of action (eds Feingold, K. R. et al.) (Endotext, 2021).
Hewison, M. & Adams, J. S. Extrarenal 1α-hydroxylase. In: Vitamin D, 3rd edn. (eds Feldman, D., Pike, J. W. & Adams, J. S.) 777–806 (Academic Press, 2011).
Daiger, S. P., Schanfield, M. S. & Cavalli-Sforza, L. L. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc. Natl Acad. Sci. USA 72, 2076–2080 (1975).
pubmed: 49052
pmcid: 432697
doi: 10.1073/pnas.72.6.2076
Pike, J. W. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand. Mol. Cell Endocrinol. 347, 3–10 (2011).
pubmed: 21664239
pmcid: 3179550
doi: 10.1016/j.mce.2011.05.012
Carlberg, C. Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 5, 167 (2014).
pubmed: 24808867
pmcid: 4010781
doi: 10.3389/fphys.2014.00167
Donati, S. et al. Rapid nontranscriptional effects of calcifediol and calcitriol. Nutrients 14, 1291 (2022).
pubmed: 35334948
pmcid: 8951353
doi: 10.3390/nu14061291
Latini, A. et al. VDR polymorphisms in autoimmune connective tissue diseases: focus on Italian population. J. Immunol. Res. 2021, 5812136 (2021).
pubmed: 34977255
pmcid: 8718283
doi: 10.1155/2021/5812136
Bikle, D. D. Vitamin D regulation of and by long non coding RNAs. Mol. Cell Endocrinol. 532, 111317 (2021).
pubmed: 34015414
doi: 10.1016/j.mce.2021.111317
Williams, C. J. B. Cod-liver oil in phthisis. Lond. J. Med. 1, 1–18 (1849).
pmcid: 2543222
Finsen, N. R. Om Bekæmpelse af Lupus vulgaris med en Redegørelse for de i Danmark opnaaede Resultater. (Gyldendalske Boghandels Forlag, 1902).
Van Der Lugt, L. & Rottier, P. B. Finsen therapy and vitamin D. Acta Derm. Venereol. 38, 264–273 (1958).
pubmed: 13594215
Overbergh, L. et al. Identification and immune regulation of 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages. Clin. Exp. Immunol. 120, 139–146 (2000).
pubmed: 10759775
pmcid: 1905630
doi: 10.1046/j.1365-2249.2000.01204.x
Stoffels, K. et al. Immune regulation of 25-hydroxyvitamin-D
doi: 10.1359/JBMR.050908
Merriman, K. E., Powell, J. L., Santos, J. E. P. & Nelson, C. D. Intramammary 25-hydroxyvitamin D
pubmed: 29753474
doi: 10.3168/jds.2017-14143
Takahashi, K. et al. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1α,25-dihydroxyvitamin D
pubmed: 12375732
doi: 10.1081/IPH-120014721
Bishop, E. L., Ismailova, A., Dimeloe, S., Hewison, M. & White, J. H. Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory. JBMR Plus 5, e10405 (2020).
Karlsson, J., Carlsson, G., Larne, O., Andersson, M. & Pütsep, K. Vitamin D
pubmed: 18703682
doi: 10.1189/jlb.0607437
Yim, S., Dhawan, P., Ragunath, C., Christakos, S. & Diamond, G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D
pubmed: 17467345
pmcid: 2099696
doi: 10.1016/j.jcf.2007.03.003
Wang, T. T. et al. Cutting edge: 1,25-dihydroxyvitamin D
pubmed: 15322146
doi: 10.4049/jimmunol.173.5.2909
Wang, T. T. et al. Direct and indirect induction by 1,25-dihydroxyvitamin D
pubmed: 19948723
doi: 10.1074/jbc.C109.071225
Ota, K. et al. 1,25-Dihydroxy-vitamin D
pubmed: 26257123
doi: 10.1002/eji.201545541
Verway, M. et al. Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog. 9, e1003407 (2013).
pubmed: 23762029
pmcid: 3675149
doi: 10.1371/journal.ppat.1003407
Chauss, D. et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of T
pubmed: 34764490
doi: 10.1038/s41590-021-01080-3
Wang, Q. et al. Vitamin D inhibits COX-2 expression and inflammatory response by targeting thioesterase superfamily member 4. J. Biol. Chem. 289, 11681–11694 (2014).
pubmed: 24619416
pmcid: 4002078
doi: 10.1074/jbc.M113.517581
Piemonti, L. et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164, 4443–4451 (2000).
pubmed: 10779743
doi: 10.4049/jimmunol.164.9.4443
Széles, L. et al. 1,25-dihydroxyvitamin D
pubmed: 19201860
doi: 10.4049/jimmunol.0803345
D’Ambrosio, D. et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D
pubmed: 9421488
pmcid: 508562
doi: 10.1172/JCI1050
Davies, L. C., Jenkins, S. J., Allen, J. E. & Taylor, P. R. Tissue-resident macrophages. Nat. Immunol. 14, 986–995 (2013).
pubmed: 24048120
pmcid: 4045180
doi: 10.1038/ni.2705
Zhu, X. et al. 1,25 Dihydroxyvitamin D regulates macrophage polarization and ameliorates experimental inflammatory bowel disease by suppressing miR-125b. Int. Immunopharmacol. 67, 106–118 (2019).
pubmed: 30540970
doi: 10.1016/j.intimp.2018.12.015
Cutolo, M., Campitiello, R., Gotelli, E. & Soldano, S. The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis. Front. Immunol. 13, 867260 (2022).
pubmed: 35663975
pmcid: 9161083
doi: 10.3389/fimmu.2022.867260
Verma, R. & Kim, J. Y. 1,25-Dihydroxyvitamin D
pubmed: 26999663
doi: 10.1159/000444300
Dionne, S., Duchatelier, C. F. & Seidman, E. G. The influence of vitamin D on M1 and M2 macrophages in patients with Crohn’s disease. Innate Immun. 23, 557–565 (2017).
pubmed: 28770666
doi: 10.1177/1753425917721965
Rao Muvva, J., Parasa, V. R., Lerm, M., Svensson, M. & Brighenti, S. Polarization of human monocyte-derived cells with vitamin D promotes control of Mycobacterium tuberculosis infection. Front. Immunol. 10, 3157 (2020).
pubmed: 32038652
pmcid: 6987394
doi: 10.3389/fimmu.2019.03157
Liang, S., Cai, J., Li, Y. & Yang, R. 1,25 Dihydroxy vitamin D
pubmed: 30896850
pmcid: 6472136
Cantorna, M. T., Yu, S. & Bruce, D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Asp. Med. 29, 369–375 (2008).
doi: 10.1016/j.mam.2008.04.004
Baeke, F., Takiishi, T., Korf, H., Gysemans, C. & Mathieu, C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482–496 (2010).
pubmed: 20427238
doi: 10.1016/j.coph.2010.04.001
Bikle, D. D. Vitamin D regulation of immune function during COVID-19. Rev. Endocr. Metab. Disord. 23, 279–285 (2022).
pubmed: 35091881
pmcid: 8799423
doi: 10.1007/s11154-021-09707-4
Holt, P. G., Strickland, D. H., Wikström, M. E. & Jahnsen, F. L. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8, 142–152 (2008).
pubmed: 18204469
doi: 10.1038/nri2236
Hewison, M. et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170, 5382–5390 (2003).
pubmed: 12759412
doi: 10.4049/jimmunol.170.11.5382
Fritsche, J., Mondal, K., Ehrnsperger, A., Andreesen, R. & Kreutz, M. Regulation of 25-hydroxyvitamin D
pubmed: 12855575
doi: 10.1182/blood-2002-11-3521
van Etten, E. & Mathieu, C. Immunoregulation by 1,25-dihydroxyvitamin D
pubmed: 16046118
doi: 10.1016/j.jsbmb.2005.06.002
Daniel, C., Sartory, N. A., Zahn, N., Radeke, H. H. & Stein, J. M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324, 23–33 (2008).
pubmed: 17911375
doi: 10.1124/jpet.107.127209
Gregori, S. et al. Regulatory T cells induced by 1α,25-dihydroxyvitamin D
pubmed: 11489974
doi: 10.4049/jimmunol.167.4.1945
Sloka, S., Silva, C., Wang, J. & Yong, V. W. Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J. Neuroinflammation 8, 56 (2011).
pubmed: 21605467
pmcid: 3118349
doi: 10.1186/1742-2094-8-56
Horiuchi, S. et al. Genome-wide analysis reveals unique regulation of transcription of Th2-specific genes by GATA3. J. Immunol. 186, 6378–6389 (2011).
pubmed: 21536806
doi: 10.4049/jimmunol.1100179
Sharif, K. et al. Vitamin D, autoimmunity and recurrent pregnancy loss: more than an association. Am. J. Reprod. Immunol. 80, e12991 (2018).
pubmed: 29923244
doi: 10.1111/aji.12991
Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).
pubmed: 18510923
doi: 10.1016/j.cell.2008.05.009
Barrat, F. J. et al. In vitro generation of interleukin 10-producing regulatory CD4
pubmed: 11877483
pmcid: 2193760
doi: 10.1084/jem.20011629
Penna, G. & Adorini, L. 1α,25-dihydroxyvitamin D
pubmed: 10679076
doi: 10.4049/jimmunol.164.5.2405
Drozdenko, G., Scheel, T., Heine, G., Baumgrass, R. & Worm, M. Impaired T cell activation and cytokine production by calcitriol-primed human B cells. Clin. Exp. Immunol. 178, 364–372 (2014).
pubmed: 24965738
pmcid: 4233385
doi: 10.1111/cei.12406
Morgan, J. W., Sliney, D. J., Morgan, D. M. & Maizel, A. L. Differential regulation of gene transcription in subpopulations of human B lymphocytes by vitamin D
pubmed: 9886849
doi: 10.1210/endo.140.1.6395
Chen, S. et al. Modulatory effects of 1,25-dihydroxyvitamin D
pubmed: 17641030
doi: 10.4049/jimmunol.179.3.1634
Drozdenko, G., Heine, G. & Worm, M. Oral vitamin D increases the frequencies of CD38
pubmed: 24313624
doi: 10.1111/exd.12300
Piedra-Quintero, Z. L., Wilson, Z., Nava, P. & Guerau-de-Arellano, M. CD38: an immunomodulatory molecule in inflammation and autoimmunity. Front. Immunol. 11, 597959 (2020).
pubmed: 33329591
pmcid: 7734206
doi: 10.3389/fimmu.2020.597959
James, J., Weaver, V. & Cantorna, M. T. Control of circulating IgE by the vitamin D receptor in vivo involves B cell intrinsic and extrinsic mechanisms. J. Immunol. 198, 1164–1171 (2017).
pubmed: 28003380
doi: 10.4049/jimmunol.1601213
de Vries, J. E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27, 537–541 (1995).
pubmed: 8541028
doi: 10.3109/07853899509002465
Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O’Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683–765 (2001).
pubmed: 11244051
doi: 10.1146/annurev.immunol.19.1.683
Charoenngam, N. & Holick, M. F. Immunologic effects of vitamin D on human health and disease. Nutrients 12, 2097 (2020).
pubmed: 32679784
pmcid: 7400911
doi: 10.3390/nu12072097
Cutolo, M., Plebani, M., Shoenfeld, Y., Adorini, L. & Tincani, A. Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam. Horm. 86, 327–351 (2011).
pubmed: 21419278
doi: 10.1016/B978-0-12-386960-9.00014-9
Cutolo, M. et al. Vitamin D, steroid hormones, and autoimmunity. Ann. N. Y. Acad. Sci. 1317, 39–46 (2014).
pubmed: 24739090
doi: 10.1111/nyas.12432
Hidalgo, A. A., Deeb, K. K., Pike, J. W., Johnson, C. S. & Trump, D. L. Dexamethasone enhances 1α,25-dihydroxyvitamin D
pubmed: 21868377
pmcid: 3196110
doi: 10.1074/jbc.M111.244061
Dhawan, P. & Christakos, S. Novel regulation of 25-hydroxyvitamin D
pubmed: 20564225
doi: 10.1002/jcb.22645
Kurahashi, I., Matsunuma, A., Kawane, T., Abe, M. & Horiuchi, N. Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1α,25-dihydroxyvitamin D
pubmed: 12041912
doi: 10.1385/ENDO:17:2:109
Jiang, P. et al. Dysregulation of vitamin D metabolism in the brain and myocardium of rats following prolonged exposure to dexamethasone. Psychopharmacology 231, 3445–3451 (2014).
pubmed: 24448902
doi: 10.1007/s00213-014-3440-6
Eyles, D. W., Smith, S., Kinobe, R., Hewison, M. & McGrath, J. J. Distribution of the vitamin D receptor and 1 α-hydroxylase in human brain. J. Chem. Neuroanat. 29, 21–30 (2005).
pubmed: 15589699
doi: 10.1016/j.jchemneu.2004.08.006
Moore, M., Piazza, A., Nolan, Y. & Lynch, M. A. Treatment with dexamethasone and vitamin D
pubmed: 17621647
doi: 10.1002/syn.20433
Xystrakis, E. et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J. Clin. Invest. 116, 146–155 (2006).
pubmed: 16341266
doi: 10.1172/JCI21759
Rolf, L., Damoiseaux, J., Hupperts, R., Huitinga, I. & Smolders, J. Network of nuclear receptor ligands in multiple sclerosis: common pathways and interactions of sex-steroids, corticosteroids and vitamin D
doi: 10.1016/j.autrev.2016.07.002
Andersson, A. M., Carlsen, E., Petersen, J. H. & Skakkebaek, N. E. Variation in levels of serum inhibin B, testosterone, estradiol, luteinizing (83) hormone, follicle-stimulating hormone, and sex hormone-binding globulin in monthly samples from healthy men during a 17-month period: possible effects of seasons. J. Clin. Endocrinol. Metab. 88, 932–937 (2003).
pubmed: 12574235
doi: 10.1210/jc.2002-020838
Yague, J. G., Garcia-Segura, L. M. & Azcoitia, I. Selective transcriptional regulation of aromatase gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine 35, 252–261 (2009).
pubmed: 19116788
doi: 10.1007/s12020-008-9134-2
Enjuanes, A. et al. Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation. Eur. J. Endocrinol. 153, 981–988 (2005).
pubmed: 16322405
doi: 10.1530/eje.1.02032
Lou, Y. R., Murtola, T. & Tuohimaa, P. Regulation of aromatase and 5α-reductase by 25-hydroxyvitamin D(3), 1α,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells. J. Steroid Biochem. Mol. Biol. 94, 151–157 (2005).
pubmed: 15862960
doi: 10.1016/j.jsbmb.2005.01.024
Villaggio, B., Soldano, S. & Cutolo, M. 1,25-dihydroxyvitamin D
pubmed: 23253631
Nashold, F. E., Spach, K. M., Spanier, J. A. & Hayes, C. E. Estrogen controls vitamin D
pubmed: 19710457
doi: 10.4049/jimmunol.0901351
Liel, Y., Kraus, S., Levy, J. & Shany, S. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). Endocrinology 130, 2597–2601 (1992).
pubmed: 1315250
doi: 10.1210/endo.130.5.1315250
Escaleira, M. T., Sonohara, S. & Brentani, M. M. Sex steroids induced up-regulation of 1,25-(OH)2 vitamin D
pubmed: 8388708
doi: 10.1016/0960-0760(93)90340-3
Schwartz, B., Smirnoff, P., Shany, S. & Liel, Y. Estrogen controls expression and bioresponse of 1,25-dihydroxyvitamin D receptors in the rat colon. Mol. Cell Biochem. 203, 87–93 (2000).
pubmed: 10724336
doi: 10.1023/A:1007015027268
Liel, Y., Shany, S., Smirnoff, P. & Schwartz, B. Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140, 280–285 (1999).
pubmed: 9886836
doi: 10.1210/endo.140.1.6408
Bikle, D. D., Gee, E., Halloran, B. & Haddad, J. G. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J. Clin. Invest. 74, 1966–1971 (1984).
pubmed: 6549014
pmcid: 425383
doi: 10.1172/JCI111617
Buchanan, J. R. et al. The effect of endogenous estrogen fluctuation on metabolism of 25-hydroxyvitamin D. Calcif. Tissue Int. 39, 139–144 (1986).
pubmed: 3093024
doi: 10.1007/BF02555109
Dupuis, M. L., Pagano, M. T., Pierdominici, M. & Ortona, E. The role of vitamin D in autoimmune diseases: could sex make the difference? Biol. Sex. Differ. 12, 12 (2021).
pubmed: 33436077
pmcid: 7802252
doi: 10.1186/s13293-021-00358-3
Thangamani, S. et al. Cutting edge: Progesterone directly upregulates vitamin D receptor gene expression for efficient regulation of T cells by calcitriol. J. Immunol. 194, 883–886 (2015).
pubmed: 25548222
doi: 10.4049/jimmunol.1401923
Cutolo, M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res. Ther. 10, 123 (2008).
pubmed: 19090978
pmcid: 2656237
doi: 10.1186/ar2552
Cutolo, M. Vitamin D and autoimmune rheumatic diseases. Rheumatology 48, 210–212 (2009).
pubmed: 18930963
doi: 10.1093/rheumatology/ken394
Cutolo, M., Pizzorni, C. & Sulli, A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun. Rev. 11, 84–87 (2011).
pubmed: 21864722
doi: 10.1016/j.autrev.2011.08.003
Cutolo, M. Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann. Rheum. Dis. 72, 473–475 (2013).
pubmed: 23440106
doi: 10.1136/annrheumdis-2012-202538
Cutolo, M. et al. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann. Rheum. Dis. 68, 446–447 (2009).
pubmed: 19213751
doi: 10.1136/ard.2008.093476
Staples, J. A., Ponsonby, A. L., Lim, L. L. & McMichael, A. J. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Env. Health Perspect. 111, 518–523 (2003).
doi: 10.1289/ehp.5941
Vieira, V. M. et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses’ Health Study. Environ. Health Perspect. 118, 957–961 (2010).
pubmed: 20338859
pmcid: 2920915
doi: 10.1289/ehp.0901861
Bouillon, R. Comparative analysis of nutritional guidelines for vitamin D. Nat. Rev. Endocrinol. 13, 466–479 (2017).
pubmed: 28387318
doi: 10.1038/nrendo.2017.31
Aslam, M. M., John, P., Bhatti, A., Jahangir, S. & Kamboh, M. I. Vitamin D as a principal factor in mediating rheumatoid arthritis-derived immune response. Biomed. Res. Int. 2019, 3494937 (2019).
pubmed: 31205940
pmcid: 6530219
doi: 10.1155/2019/3494937
Paradowska-Gorycka, A. et al. Th17/Treg-Related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis. Front. Immunol. 11, 3189 (2020).
doi: 10.3389/fimmu.2020.572858
Kosmaczewska, A., Swierkot, J., Ciszak, L. & Wiland, P. The role of Th1, Th17, and Treg cells in the pathogenesis of rheumatoid arthritis including anti-inflammatory action of Th1 cytokines. Postepy Hig. Med. Dosw. 65, 397–403 (2011).
doi: 10.5604/17322693.948971
Buckland, J. Rheumatoid arthritis: control of T
pubmed: 22270075
doi: 10.1038/nrrheum.2012.3
Mateen, S., Moin, S., Shahzad, S. & Khan, A. Q. Level of inflammatory cytokines in rheumatoid arthritis patients: correlation with 25-hydroxy vitamin D and reactive oxygen species. PLoS One 12, e0178879 (2017).
pubmed: 28594861
pmcid: 5464597
doi: 10.1371/journal.pone.0178879
Bagheri-Hosseinabadi, Z. et al. Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis. Clin. Rheumatol. 39, 3555–3569 (2020).
pubmed: 32445089
doi: 10.1007/s10067-020-05143-y
Rozmus, D. et al. Vitamin D Binding Protein (VDBP) and its gene polymorphisms-the risk of malignant tumors and other diseases. Int. J. Mol. Sci. 21, 7822 (2020).
pubmed: 33105665
pmcid: 7659952
doi: 10.3390/ijms21217822
Arkema, E. V. et al. Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses’ Health Study. Ann. Rheum. Dis. 72, 506–511 (2013).
pubmed: 23380431
doi: 10.1136/annrheumdis-2012-202302
Costenbader, K. H., Chang, S. C., Laden, F., Puett, R. & Karlson, E. W. Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch. Intern. Med. 168, 1664–1670 (2008).
pubmed: 18695080
pmcid: 2732358
doi: 10.1001/archinte.168.15.1664
Hajjaj-Hassouni, N. et al. Evaluation of vitamin D status in rheumatoid arthritis and its association with disease activity across 15 countries: “The COMORA Study”. Int. J. Rheumatol. 2017, 5491676 (2017).
pubmed: 28656048
pmcid: 5471553
doi: 10.1155/2017/5491676
Mouterde, G. et al. Association between vitamin D deficiency and disease activity, disability, and radiographic progression in early rheumatoid arthritis: the ESPOIR Cohort. J. Rheumatol. 47, 1624–1628 (2020).
pubmed: 31839594
doi: 10.3899/jrheum.190795
Merlino, L. A. et al. Iowa Women’s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum. 50, 72–77 (2004).
pubmed: 14730601
doi: 10.1002/art.11434
Guan, Y., Hao, Y., Guan, Y., Bu, H. & Wang, H. The effect of vitamin D supplementation on rheumatoid arthritis patients: a systematic review and meta-analysis. Front. Med. 7, 596007 (2020).
doi: 10.3389/fmed.2020.596007
Nguyen, Y. et al. Efficacy of oral vitamin supplementation in inflammatory rheumatic disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrients 13, 107 (2020).
pubmed: 33396851
pmcid: 7824121
doi: 10.3390/nu13010107
Yang, J., Liu, L., Zhang, Q., Li, M. & Wang, J. Effect of vitamin D on the recurrence rate of rheumatoid arthritis. Exp. Ther. Med. 10, 1812–1816 (2015).
pubmed: 26640554
pmcid: 4665932
doi: 10.3892/etm.2015.2747
Gopinath, K. & Danda, D. Supplementation of 1,25 dihydroxy vitamin D
pubmed: 22004229
doi: 10.1111/j.1756-185X.2011.01684.x
Li, C. et al. Efficacy and safety of 22-oxa-calcitriol in patients with rheumatoid arthritis: a phase II trial. Med. Sci. Monit. 24, 9127–9135 (2018).
pubmed: 30554233
pmcid: 6319165
doi: 10.12659/MSM.911628
Mukherjee, D., Lahiry, S., Thakur, S. & Chakraborty, D. S. Effect of 1,25 dihydroxy vitamin D
doi: 10.4103/jfmpc.jfmpc_446_18
Buondonno, I. et al. Vitamin D and immunomodulation in early rheumatoid arthritis: a randomized double-blind placebo-controlled study. PLoS One 12, e0178463 (2017).
pubmed: 28582403
pmcid: 5459341
doi: 10.1371/journal.pone.0178463
Adami, G. et al. An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis. Mod. Rheumatol. 29, 1059–1062 (2019).
pubmed: 30285521
doi: 10.1080/14397595.2018.1532622
Salesi, M. & Farajzadegan, Z. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatol. Int. 32, 2129–2133 (2012).
pubmed: 21523344
doi: 10.1007/s00296-011-1944-5
Dehghan, A., Rahimpour, S., Soleymani-Salehabadi, H. & Owlia, M. B. Role of vitamin D in flare ups of rheumatoid arthritis. Z. Rheumatol. 73, 461–464 (2014).
pubmed: 24352479
doi: 10.1007/s00393-013-1297-4
Matsumoto, Y. et al. Relationships between serum 25-hydroxycalciferol, vitamin D intake and disease activity in patients with rheumatoid arthritis–TOMORROW study. Mod. Rheumatol. 25, 246–250 (2015).
pubmed: 25211403
doi: 10.3109/14397595.2014.952487
Franco, A. S., Freitas, T. Q., Bernardo, W. M. & Pereira, R. M. R. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis. Medicine 96, e7024 (2017).
pubmed: 28591033
pmcid: 5466211
doi: 10.1097/MD.0000000000007024
Wu, J. et al. The role of vitamin D in combination treatment for patients with rheumatoid arthritis. Front. Med. 7, 312 (2020).
doi: 10.3389/fmed.2020.00312
Hahn, J. et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ 376, e066452 (2022).
pubmed: 35082139
pmcid: 8791065
doi: 10.1136/bmj-2021-066452
Suárez-Fueyo, A., Bradley, S. J. & Tsokos, G. C. T cells in systemic lupus erythematosus. Curr. Opin. Immunol. 43, 32–38 (2016).
pubmed: 27636649
pmcid: 5125867
doi: 10.1016/j.coi.2016.09.001
Han, S., Zhuang, H., Shumyak, S., Yang, L. & Reeves, W. H. Mechanisms of autoantibody production in systemic lupus erythematosus. Front. Immunol. 6, 228 (2015).
pubmed: 26029213
pmcid: 4429614
doi: 10.3389/fimmu.2015.00228
Postal, M. et al. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus. Cytokine 61, 785–791 (2013).
pubmed: 23332615
doi: 10.1016/j.cyto.2012.11.023
Muhammad Yusoff, F., Wong, K. K. & Mohd Redzwan, N. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity 53, 8–20 (2020).
pubmed: 31771364
doi: 10.1080/08916934.2019.1693545
Sahebari, M., Nabavi, N. & Salehi, M. Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum Vit D confounders. Lupus 23, 1164–1177 (2014).
pubmed: 24961748
doi: 10.1177/0961203314540966
Islam, M. A., Khandker, S. S., Alam, S. S., Kotyla, P. & Hassan, R. Vitamin D status in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Autoimmun. Rev. 18, 102392 (2019).
pubmed: 31520805
doi: 10.1016/j.autrev.2019.102392
Monticielo, O. A. et al. Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin. Rheumatol. 31, 1411–1421 (2012).
pubmed: 22692397
doi: 10.1007/s10067-012-2021-5
Sun, J., Zhang, S., Liu, J. S., Gui, M. & Zhang, H. Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity. Lupus 28, 290–294 (2019).
pubmed: 30691345
doi: 10.1177/0961203319826704
Linker-Israeli, M., Elstner, E., Klinenberg, J. R., Wallace, D. J. & Koeffler, H. P. Vitamin D
pubmed: 11286544
doi: 10.1006/clim.2000.4998
Terrier, B. et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther. 14, R221 (2012).
pubmed: 23075451
pmcid: 3580532
doi: 10.1186/ar4060
Lerman, M., Burnham, J. & Behrens, E. 1,25 Dihydroxyvitamin D
pubmed: 21447602
doi: 10.1177/0961203310394542
Ben-Zvi, I. et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One 5, e9193 (2010).
pubmed: 20169063
pmcid: 2821911
doi: 10.1371/journal.pone.0009193
Barbhaiya, M. & Costenbader, K. H. Ultraviolet radiation and systemic lupus erythematosus. Lupus 23, 588–595 (2014).
pubmed: 24763542
doi: 10.1177/0961203314530488
Vearing, R. M. et al. Vitamin D status of the British African-Caribbean residents: analysis of the UK Biobank Cohort. Nutrients 13, 4104 (2021).
pubmed: 34836358
pmcid: 8620024
doi: 10.3390/nu13114104
Williams, E. M. et al. I too, am America: a review of research on systemic lupus erythematosus in African-Americans. Lupus Sci. Med. 3, e000144 (2016).
pubmed: 27651918
pmcid: 5013381
doi: 10.1136/lupus-2015-000144
Petri, M., Bello, K. J., Fang, H. & Magder, L. S. Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 65, 1865–1871 (2013).
pubmed: 23553077
pmcid: 3701725
doi: 10.1002/art.37953
Andreoli, L. et al. A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus 24, 499–506 (2015).
pubmed: 25801893
doi: 10.1177/0961203314559089
Karimzadeh, H., Shirzadi, M. & Karimifar, M. The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: a randomized clinical trial. J. Res. Med. Sci. 27, 22–24 (2017).
Lima, G. L. et al. Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. 68, 91–98 (2016).
doi: 10.1002/acr.22621
Sumethkul, K. et al. The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus. Rheumatol. Int. 33, 1461–1467 (2013).
pubmed: 23179257
doi: 10.1007/s00296-012-2537-7
Yu, Q. et al. Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy. Arthritis Res. Ther. 21, 19 (2019).
pubmed: 30635032
pmcid: 6330406
doi: 10.1186/s13075-018-1803-9
Bellan, M. et al. Pathophysiological role and therapeutic implications of vitamin D in autoimmunity: focus on chronic autoimmune diseases. Nutrients 12, 789 (2020).
pubmed: 32192175
pmcid: 7146294
doi: 10.3390/nu12030789
Piantoni, S. et al. Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus 24, 490–498 (2015).
pubmed: 25801892
doi: 10.1177/0961203314559090
Ruiz-Irastorza, G., Gordo, S., Olivares, N., Egurbide, M. V. & Aguirre, C. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res. 62, 1160–1165 (2010).
doi: 10.1002/acr.20186
Mak, A. The impact of Vitamin D on the immunopathophysiology, disease activity, and extra-musculoskeletal manifestations of systemic lupus erythematosus. Int. J. Mol. Sci. 19, 2355 (2018).
pubmed: 30103428
pmcid: 6121378
doi: 10.3390/ijms19082355
Sabio, J. M., Vargas-Hitos, J. A., Martínez-Bordonado, J. & Mediavilla-García, J. D. Association between non-dipper hypertension and vitamin D deficiency in women with systemic lupus erythematosus. Clin. Exp. Rheumatol. 37, 286–292 (2019).
pubmed: 30183606
Nguyen, M. H., Bryant, K. & O’Neill, S. G. Vitamin D in SLE: a role in pathogenesis and fatigue? A review of the literature. Lupus 27, 2003–2011 (2018).
pubmed: 30157716
doi: 10.1177/0961203318796293
Mok, C. C., Bro, E. T., Ho, L. Y., Singh, R. J. & Jannetto, P. J. Serum 25-hydroxyvitamin D
pubmed: 30014357
doi: 10.1007/s10067-018-4204-1
Dall’Ara, F., Cutolo, M., Andreoli, L., Tincani, A. & Paolino, S. Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects. Clin. Exp. Rheumatol. 36, 153–162 (2018).
pubmed: 29148401
Dutta, C., Kakati, S., Barman, B. & Bora, K. Vitamin D status and its relationship with systemic lupus erythematosus as a determinant and outcome of disease activity. Horm. Mol. Biol. Clin. Investig. https://doi.org/10.1515/hmbci-2018-0064 (2019).
doi: 10.1515/hmbci-2018-0064
pubmed: 30943171
Guan, S. Y. et al. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: a systematic review and meta-analysis. Int. J. Rheum. Dis. 22, 1803–1813 (2019).
pubmed: 31468723
doi: 10.1111/1756-185X.13676
An, L., Sun, M. H., Chen, F. & Li, J. R. Vitamin D levels in systemic sclerosis patients: a meta-analysis. Drug Des. Dev. Ther. 11, 3119–3125 (2017).
doi: 10.2147/DDDT.S144860
Corrado, A. et al. Relationship between body mass composition, bone mineral density, skin fibrosis and 25(OH) Vitamin D serum levels in systemic sclerosis. PLoS One 10, e0137912 (2015).
pubmed: 26375284
pmcid: 4572708
doi: 10.1371/journal.pone.0137912
Groseanu, L. et al. Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur. J. Rheumatol. 3, 50–55 (2016).
pubmed: 27708971
pmcid: 5042230
doi: 10.5152/eurjrheum.2015.0065
Diaconu, A. D. et al. Role of Vitamin D in systemic sclerosis: a systematic literature review. J. Immunol. Res. 2021, 9782994 (2021).
pubmed: 34881335
pmcid: 8648450
doi: 10.1155/2021/9782994
Caimmi, C. et al. Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: a longitudinal study. Int. J. Rheum. Dis. 22, 1041–1045 (2019).
pubmed: 30938067
Arnson, Y. et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun. Rev. 10, 490–494 (2011).
pubmed: 21320645
doi: 10.1016/j.autrev.2011.02.002
Atteritano, M. et al. Skin involvement and pulmonary hypertension are associated with vitamin D insufficiency in scleroderma. Int. J. Mol. Sci. 17, 2103 (2016).
pubmed: 27983651
pmcid: 5187903
doi: 10.3390/ijms17122103
Humbert, P. et al. Treatment of scleroderma with oral 1,25-dihydroxyvitamin D
pubmed: 7906461
Gambichler, T., Chrobok, I., Höxtermann, S. & Kreuter, A. Significantly decreased serum 25-hydroxyvitamin D levels in a large German systemic sclerosis cohort. J. Rheumatol. 38, 2492–2493 (2011).
pubmed: 22045936
doi: 10.3899/jrheum.110695
Zhang, L. et al. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. Int. J. Rheum. Dis. 20, 1002–1008 (2017).
pubmed: 26619796
doi: 10.1111/1756-185X.12794
Cutolo, M. & Smith, V. Detection of microvascular changes in systemic sclerosis and other rheumatic diseases. Nat. Rev. Rheumatol. 17, 665–677 (2021).
pubmed: 34561652
doi: 10.1038/s41584-021-00685-0
Sampaio-Barros, M. M., Takayama, L., Sampaio-Barros, P. D., Bonfá, E. & Pereira, R. M. Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findings. Rev. Bras. Reumatol. Engl. Ed. 56, 337–344 (2016).
pubmed: 27476627
Caramaschi, P. et al. Very low levels of vitamin D in systemic sclerosis patients. Clin. Rheumatol. 29, 1419–1425 (2010).
pubmed: 20454816
doi: 10.1007/s10067-010-1478-3
Corallo, C. et al. Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features. Rheumatol. Int. 39, 1767–1775 (2019).
pubmed: 31372720
doi: 10.1007/s00296-019-04401-w
Trombetta, A. C. et al. Vitamin D deficiency and clinical correlations in systemic sclerosis patients: a retrospective analysis for possible future developments. PLoS One 12, e0179062 (2017).
pubmed: 28598975
pmcid: 5466326
doi: 10.1371/journal.pone.0179062
Shinjo, S. K., Bonfá, E., de Falco Caparbo, V. & Pereira, R. M. Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency. Rheumatol. Int. 31, 1075–1080 (2011).
pubmed: 20336459
doi: 10.1007/s00296-010-1421-6
Cutolo, M., Soldano, S., Sulli, A., Smith, V. & Gotelli, E. Influence of seasonal vitamin D changes on clinical manifestations of rheumatoid arthritis and systemic sclerosis. Front. Immunol. 12, 683665 (2021).
pubmed: 34267753
pmcid: 8276051
doi: 10.3389/fimmu.2021.683665
Cutolo, M., Otsa, K., Uprus, M., Paolino, S. & Seriolo, B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev. 7, 59–64 (2007).
pubmed: 17967727
doi: 10.1016/j.autrev.2007.07.001
Jenkinson, C. et al. High throughput LC-MS/MS method for the simultaneous analysis of multiple vitamin D analytes in serum. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1014, 56–63 (2016).
doi: 10.1016/j.jchromb.2016.01.049
De Jong, S. et al. Seasonal changes in gene expression represent cell-type composition in whole blood. Hum. Mol. Genet. 23, 2721–2728 (2014). Bronson, F. H. Are humans seasonally photoperiodic? J. Biol. Rhythm. 19, 180–192 (2004).
Dopico, X. C. et al. Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat. Commun. 12, 7000 (2015).
doi: 10.1038/ncomms8000
Khoo, A. L. et al. Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin. Exp. Immunol. 164, 72–79 (2011).
pubmed: 21323660
pmcid: 3074219
doi: 10.1111/j.1365-2249.2010.04315.x
Khoo, A. L. et al. Seasonal variation in vitamin D
pubmed: 22235276
pmcid: 3250425
doi: 10.1371/journal.pone.0029250
Iikuni, N. et al. What’s in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatol 46, 846–848 (2007).
doi: 10.1093/rheumatology/kel414
Mori, H. et al. Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritis. BMC Musculoskelet. Disord. 20, 30 (2019).
pubmed: 30658609
pmcid: 6339394
doi: 10.1186/s12891-019-2418-2
Feldthusen, C., Grimby-Ekman, A., Forsblad-d’Elia, H., Jacobsson, L. & Mannerkorpi, K. Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study. BMC Musculoskelet. Disord. 17, 59 (2016).
pubmed: 26846791
pmcid: 4743196
doi: 10.1186/s12891-016-0911-4
Mouterde, G. et al. Predictors of radiographic progression in the ESPOIR Cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann. Rheum. Dis. 70, 1251–1256 (2011).
pubmed: 21515603
doi: 10.1136/ard.2010.144402
Herly, M. et al. Impact of season on the association between vitamin D levels at diagnosis and one-year remission in early rheumatoid arthritis. Sci. Rep. 10, 7371 (2020).
pubmed: 32355224
pmcid: 7192905
doi: 10.1038/s41598-020-64284-x
Vojinovic, J. et al. European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new patient reported outcome questionnaire (D-PRO). Autoimmun. Rev. 16, 548–554 (2017).
pubmed: 28279841
doi: 10.1016/j.autrev.2017.03.002
Cutolo, M. Rheumatoid arthritis: circadian and circannual rhythms in RA. Nat. Rev. Rheumatol. 7, 500–502 (2011).
pubmed: 21808291
doi: 10.1038/nrrheum.2011.115
Finch, S. L. et al. Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth. Nutr. Res. 92, 139–149 (2021).
pubmed: 34311227
doi: 10.1016/j.nutres.2021.05.007
Birmingham, D. J. et al. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21, 855–864 (2012).
pubmed: 22433915
doi: 10.1177/0961203312439640
Dall’Ara, F. et al. Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patients. Clin. Exp. Rheumatol. 33, 153–158 (2015).
pubmed: 25664429
Seriolo, B., Molfetta, L. & Cutolo, M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin. Rheumatol. 30, 445–446 (2011).
pubmed: 21234627
doi: 10.1007/s10067-011-1684-7
Foocharoen, C. et al. Effect of season on clinical outcomes of Thai systemic sclerosis: analysis of the Thai National Healthcare Database. Mod. Rheumatol. 30, 1025–1032 (2020).
pubmed: 31813338
doi: 10.1080/14397595.2019.1702238
Talarico, R. et al. The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET. Nat. Rev. Rheumatol. 17, 177–184 (2021).
pubmed: 33408338
pmcid: 7786339
doi: 10.1038/s41584-020-00565-z
Saadoun, D. et al. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study. Lancet Rheumatol. 3, e481–e488 (2021).
pubmed: 33942031
pmcid: 8081401
doi: 10.1016/S2665-9913(21)00112-0
Cutolo, M., Paolino, S. & Smith, V. Evidences for a protective role of vitamin D in COVID-19. RMD Open 6, e001454 (2020).
pubmed: 33372031
doi: 10.1136/rmdopen-2020-001454
Munshi, R. et al. Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J. Med. Virol. 93, 733–740 (2021).
pubmed: 32716073
doi: 10.1002/jmv.26360
Panagiotou, G. et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin. Endocrinol. 93, 508–511 (2020).
doi: 10.1111/cen.14276
Ilie, P. C., Stefanescu, S. & Smith, L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin. Exp. Res. 32, 1195–1198 (2020).
pubmed: 32377965
pmcid: 7202265
doi: 10.1007/s40520-020-01570-8
Wang, Z. et al. Association of vitamin D deficiency with COVID-19 infection severity: systematic review and meta-analysis. Clin. Endocrinol. 96, 281–287 (2022).
doi: 10.1111/cen.14540
D’Ecclesiis, O. et al. Vitamin D and SARS-CoV2 infection, severity and mortality: a systematic review and meta-analysis. PLoS One 17, e0268396 (2022).
pubmed: 35793346
pmcid: 9258852
doi: 10.1371/journal.pone.0268396
Hosseini, B., El Abd, A. & Ducharme, F. M. Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis. Nutrients 14, 2134 (2022).
pubmed: 35631275
pmcid: 9147949
doi: 10.3390/nu14102134
Borba, V. & Shoenfeld, Y. Vitamin D and immune system function in patients with COVID-19. Isr. Med. Assoc. J. 24, 439–440 (2022).
pubmed: 35819209
Martineau, A. R. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and metaanalysis of individual participant data. BMJ 15, 356:i6583 (2017).
Dissanayake, H. A. et al. Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 107, 1484–1502 (2022).
pubmed: 34894254
doi: 10.1210/clinem/dgab892
Cutolo, M., Smith, V. & Paolino, S. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination. Clin. Exp. Rheumatol. 38, 383–386 (2020).
pubmed: 32452350
Cutolo, M. & Straub, R. H. Sex steroids and autoimmune rheumatic diseases: state of the art. Nat. Rev. Rheumatol. 16, 628–644 (2020).
pubmed: 33009519
doi: 10.1038/s41584-020-0503-4
Hansdottir, S. & Monick, M. M. Vitamin D effects on lung immunity and respiratory diseases. Vitam. Horm. 86, 217–237 (2011).
pubmed: 21419273
pmcid: 3559187
doi: 10.1016/B978-0-12-386960-9.00009-5
Weir, E. K., Thenappan, T., Bhargava, M. & Chen, Y. Does vitamin D deficiency increase the severity of COVID-19? Clin. Med. 20, e107–e108 (2020).
doi: 10.7861/clinmed.2020-0301
Waldron, J. L. et al. Vitamin D: a negative acute phase reactant. J. Clin. Pathol. 66, 620–622 (2013).
pubmed: 23454726
doi: 10.1136/jclinpath-2012-201301
Yuk, J. M. et al. Vitamin D
pubmed: 19748465
doi: 10.1016/j.chom.2009.08.004
Cantorna, M. T., Snyder, L., Lin, Y. D. & Yang, L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients 7, 3011–3021 (2015).
pubmed: 25912039
pmcid: 4425186
doi: 10.3390/nu7043011
Xu, J. et al. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol. Med. Rep. 16, 7432–7438 (2017).
pubmed: 28944831
pmcid: 5865875
doi: 10.3892/mmr.2017.7546
Mohammad, S., Mishra, A. & Ashraf, M. Z. Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis. Biomolecules 9, 649 (2019).
pubmed: 31653092
pmcid: 6920963
doi: 10.3390/biom9110649
Jiang, F., Yang, Y., Xue, L., Li, B. & Zhang, Z. 1α, 25-dihydroxyvitamin D
doi: 10.3390/nu9090980
Torres, M. et al. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D. Biomed. Pharmacother. 150, 112965 (2022).
pubmed: 35468580
pmcid: 9008199
doi: 10.1016/j.biopha.2022.112965
Quesada-Gomez, J. M. & Bouillon, R. Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos. Int. 29, 1697–1711 (2018).
pubmed: 29713796
doi: 10.1007/s00198-018-4520-y
Oristrell, J. et al. Association of calcitriol supplementation with reduced COVID-19 mortality in patients with chronic kidney disease: a population-based study. Biomedicines 9, 509 (2021).
pubmed: 34063015
pmcid: 8147982
doi: 10.3390/biomedicines9050509
Villasis-Keever, M. A. et al. Efficacy and safety of Vitamin D supplementation to prevent COVID-19 in frontline healthcare workers. A randomized clinical trial. Arch. Med. Res. 53, 423–430 (2022).
pubmed: 35487792
pmcid: 9013626
doi: 10.1016/j.arcmed.2022.04.003
Maghbooli, Z. et al. Treatment with 25-Hydroxyvitamin D
pubmed: 34653608
pmcid: 8511889
doi: 10.1016/j.eprac.2021.09.016
Jaun, F. et al. High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial. Trials 23, 114 (2022).
pubmed: 35120577
pmcid: 8814790
doi: 10.1186/s13063-022-06016-2
Legacy, M. et al. Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: study protocol for a randomised, double-blind, placebo controlled clinical trial. BMJ Open 12, e057024 (2022).
pubmed: 35241474
doi: 10.1136/bmjopen-2021-057024
Chillon, T. S. et al. Relationship between vitamin D status and antibody response to COVID-19 mRNA vaccination in healthy adults. Biomedicines 9, 1714 (2021).
pubmed: 34829945
pmcid: 8615783
doi: 10.3390/biomedicines9111714
Sulli, A. et al. Vitamin D and lung outcomes in elderly COVID-19 patients. Nutrients 213, 717–723 (2021).
doi: 10.3390/nu13030717
Borsche, L., Glauner, B. & von Mendel, J. COVID-19 mortality risk correlates inversely with vitamin D
pubmed: 34684596
pmcid: 8541492
doi: 10.3390/nu13103596
Scabbia, G. et al. Does climate help modeling COVID-19 risk and to what extent? PLoS One 17, e0273078 (2022).
pubmed: 36070304
pmcid: 9451080
doi: 10.1371/journal.pone.0273078
Sharun, K., Tiwari, R. & Dha, K. COVID-19 and sunlight: Impact on SARS-CoV-2 transmissibility, morbidity, and mortality. Ann. Med. Surg. https://doi.org/10.1016/j.amsu.2021.102419 (2021).
doi: 10.1016/j.amsu.2021.102419
Hollis, B. W. Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task. J. Clin. Endocrinol. Metab. 89, 3149–3151 (2004).
pubmed: 15240585
doi: 10.1210/jc.2004-0682
Tripkovic, L. et al. Comparison of vitamin D2 and vitamin D
pubmed: 22552031
pmcid: 3349454
doi: 10.3945/ajcn.111.031070
Ketha, H. et al. Comparison of the effect of daily versus bolus dose maternal vitamin D
pubmed: 29486367
pmcid: 5878742
doi: 10.1016/j.bone.2018.02.024